J. Robert Kane

1.1k total citations
20 papers, 607 citations indexed

About

J. Robert Kane is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, J. Robert Kane has authored 20 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Genetics and 5 papers in Oncology. Recurrent topics in J. Robert Kane's work include Virus-based gene therapy research (9 papers), RNA Interference and Gene Delivery (8 papers) and CAR-T cell therapy research (4 papers). J. Robert Kane is often cited by papers focused on Virus-based gene therapy research (9 papers), RNA Interference and Gene Delivery (8 papers) and CAR-T cell therapy research (4 papers). J. Robert Kane collaborates with scholars based in United States, Mexico and Philippines. J. Robert Kane's co-authors include WM Crist, C‐H Pui, Maciej S. Lesniak, Julius W. Kim, Jacob S. Young, Deepak Kanojia, Jason Miska, Anjana V. Yeldandi, Stephen S. Yau and Craig Horbinski and has published in prestigious journals such as Clinical Cancer Research, IEEE Transactions on Software Engineering and Oncotarget.

In The Last Decade

J. Robert Kane

20 papers receiving 594 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Robert Kane United States 14 208 130 122 120 115 20 607
Ralph Rossi Australia 7 241 1.2× 133 1.0× 103 0.8× 31 0.3× 61 0.5× 11 567
Aaron D. DeWard United States 12 351 1.7× 121 0.9× 29 0.2× 26 0.2× 87 0.8× 14 697
Mohsen Sheykhhasan Iran 13 214 1.0× 186 1.4× 33 0.3× 32 0.3× 45 0.4× 35 557
Neal Goodwin United States 10 203 1.0× 252 1.9× 80 0.7× 19 0.2× 55 0.5× 15 647
Dessislava Malinova United Kingdom 14 202 1.0× 81 0.6× 34 0.3× 15 0.1× 64 0.6× 17 664
Leo Kunz Switzerland 12 198 1.0× 206 1.6× 135 1.1× 14 0.1× 131 1.1× 15 664
Axel Hyrenius‐Wittsten Sweden 7 249 1.2× 277 2.1× 31 0.3× 150 1.3× 124 1.1× 11 621
Gency Gunasingh Australia 11 227 1.1× 126 1.0× 114 0.9× 22 0.2× 69 0.6× 14 472
Jessica Foster United States 11 181 0.9× 217 1.7× 71 0.6× 17 0.1× 68 0.6× 26 447
Sanfang Tu China 16 297 1.4× 582 4.5× 56 0.5× 78 0.7× 144 1.3× 52 858

Countries citing papers authored by J. Robert Kane

Since Specialization
Citations

This map shows the geographic impact of J. Robert Kane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Robert Kane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Robert Kane more than expected).

Fields of papers citing papers by J. Robert Kane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Robert Kane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Robert Kane. The network helps show where J. Robert Kane may publish in the future.

Co-authorship network of co-authors of J. Robert Kane

This figure shows the co-authorship network connecting the top 25 collaborators of J. Robert Kane. A scholar is included among the top collaborators of J. Robert Kane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Robert Kane. J. Robert Kane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Daniel Y., Crismita Dmello, Li Chen, et al.. (2019). Ultrasound-mediated Delivery of Paclitaxel for Glioma: A Comparative Study of Distribution, Toxicity, and Efficacy of Albumin-bound Versus Cremophor Formulations. Clinical Cancer Research. 26(2). 477–486. 124 indexed citations
2.
Wu, Meijing, Jason Miska, Ting Xiao, et al.. (2019). Race influences survival in glioblastoma patients with KPS ≥ 80 and associates with genetic markers of retinoic acid metabolism. Journal of Neuro-Oncology. 142(2). 375–384. 20 indexed citations
3.
Kane, J. Robert. (2019). The Role of Brain Vasculature in Glioblastoma. Molecular Neurobiology. 56(9). 6645–6653. 48 indexed citations
4.
Kim, Julius W., J. Robert Kane, Wojciech K. Panek, et al.. (2018). A Dendritic Cell-Targeted Adenoviral Vector Facilitates Adaptive Immune Response Against Human Glioma Antigen (CMV-IE) and Prolongs Survival in a Human Glioma Tumor Model. Neurotherapeutics. 15(4). 1127–1138. 21 indexed citations
5.
Panek, Wojciech K., Katarzyna C. Pituch, Jason Miska, et al.. (2018). Local Application of Autologous Platelet-Rich Fibrin Patch (PRF-P) Suppresses Regulatory T Cell Recruitment in a Murine Glioma Model. Molecular Neurobiology. 56(7). 5032–5040. 18 indexed citations
6.
Kim, Julius W., Alan L. Chang, J. Robert Kane, et al.. (2018). Gene Therapy and Virotherapy of Gliomas. Progress in neurological surgery. 32. 112–123. 10 indexed citations
7.
Kim, Julius W., Jason Miska, Jacob S. Young, et al.. (2017). A Comparative Study of Replication-Incompetent and -Competent Adenoviral Therapy-Mediated Immune Response in a Murine Glioma Model. Molecular Therapy — Oncolytics. 5. 97–104. 16 indexed citations
8.
Panek, Wojciech K., J. Robert Kane, Jacob S. Young, et al.. (2017). Hitting the nail on the head: combining oncolytic adenovirus-mediated virotherapy and immunomodulation for the treatment of glioma. Oncotarget. 8(51). 89391–89405. 23 indexed citations
9.
Boddu, Prajwal, et al.. (2017). Pathologic and Radiologic Correlation of Adult Cystic Lung Disease: A Comprehensive Review. Pathology Research International. 2017. 1–17. 13 indexed citations
10.
Wu, Meijing, Jason Miska, Peng Zhang, et al.. (2017). PATH-44. RACE INFLUENCES PATIENT SURVIVAL IN GLIOMA AND ASSOCIATES WITH GENETIC MARKERS OF RETINOIC ACID METABOLISM. Neuro-Oncology. 19(suppl_6). vi180–vi181. 1 indexed citations
11.
Kane, J. Robert, et al.. (2016). Plexiform fibromyxoma with cotyledon-like serosal growth: A case report of a rare gastric tumor and review of the literature. Oncology Letters. 11(3). 2189–2194. 18 indexed citations
12.
Auffinger, Brenda, Drew Spencer, Jason Miska, et al.. (2016). Single dose GLP toxicity and biodistribution study of a conditionally replicative adenovirus vector, CRAd-S-pk7, administered by intracerebral injection to Syrian hamsters. Journal of Translational Medicine. 14(1). 134–134. 14 indexed citations
13.
Kane, J. Robert, Jason Miska, Jacob S. Young, et al.. (2015). Sui generis: gene therapy and delivery systems for the treatment of glioblastoma. Neuro-Oncology. 17(suppl 2). ii24–ii36. 58 indexed citations
14.
Kim, Julius W., Ramin A. Morshed, J. Robert Kane, et al.. (2015). Viral Vector Production: Adenovirus. Methods in molecular biology. 1382. 115–130. 4 indexed citations
15.
Kim, Julius W., J. Robert Kane, Jacob S. Young, et al.. (2015). A Genetically Modified Adenoviral Vector with a Phage Display-Derived Peptide Incorporated into Fiber Fibritin Chimera Prolongs Survival in Experimental Glioma. Human Gene Therapy. 26(9). 635–646. 11 indexed citations
16.
Kim, Julius W., J. Robert Kane, Jacob S. Young, et al.. (2015). Neural Stem Cell‐Mediated Delivery of Oncolytic Adenovirus. Current Protocols in Human Genetics. 85(1). 13.11.1–13.11.9. 5 indexed citations
17.
Kane, J. Robert, et al.. (2013). Sarcomatoid (spindle cell) carcinoma of the pancreas: A case report and review of the literature. Oncology Letters. 7(1). 245–249. 25 indexed citations
18.
Pui, C‐H, J. Robert Kane, & WM Crist. (1995). Biology and treatment of infant leukemias.. PubMed. 9(5). 762–9. 156 indexed citations
19.
Kane, J. Robert & Stephen S. Yau. (1975). Concurrent software fault detection. IEEE Transactions on Software Engineering. SE-1(1). 87–99. 20 indexed citations
20.
Kane, J. Robert & S. S. Yau. (1971). On the design of easily testable sequential machines. c 19. 38–42. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ralph Rossi Breakdown of academic impact, for papers by Aaron D. DeWard Breakdown of academic impact, for papers by Mohsen Sheykhhasan Breakdown of academic impact, for papers by Neal Goodwin Breakdown of academic impact, for papers by Dessislava Malinova Breakdown of academic impact, for papers by Leo Kunz Breakdown of academic impact, for papers by Axel Hyrenius‐Wittsten Breakdown of academic impact, for papers by Gency Gunasingh Breakdown of academic impact, for papers by Jessica Foster Breakdown of academic impact, for papers by Sanfang Tu
Rankless by CCL
2026